Medicare & Medicaid
News articles in this section include actions by federal regulators like the CMS and HHS, as well as information on Medicare and state Medicaid coverage and benefits.
The Wall Street Journal has added to the pressure on Medicare Advantage plan issuers by publishing its own analysis of how the issuers score their enrollees' health.
The sweeping payment rule also solidifies continuous eligibility requirements for children in Medicaid and CHIP, and holds hospitals to higher obstetric care delivery standards.
Private insurance firms running Medicare Advantage programs have been overcharging the federal government billions of dollars by making patients look sicker than they really are, according to a report in The Wall Street Journal on Monday.
As Americans tuned into the presidential debate last Thursday, critical issues like Social Security and Medicare came up. These programs act as lifelines for millions of Americans, especially seniors who have historically been a strong voting block.
The health care industry put a measure on the November ballot that would raise more money for Medi-Cal and block lawmakers from spending it on general government services. Billions of dollars are on the line.
A provision of Biden’s Inflation Reduction Act requires drugmakers to pay rebates to Medicare if they hike the price of a medication faster than the rate of inflation.
Gov. Gavin Newsom, state lawmakers, and health industry leaders have a small window to reach an agreement on billions of new dollars for Medi-Cal before it’s put to voters in November.
(Editor’s Note: the KFF Health story identified California as having in excess of $500 million in Deloitte Medicaid contracts) Deloitte, a global consultancy that reported revenue last year of $65 billion, pulls in billions of dollars from states and the federal government for supplying technology it says will modernize Medicaid. The company promotes itself as the industry ...
Insured patients are often better off buying their generic prescriptions through their health insurance benefits than through Mark Cuban Cost Plus Drug Company, though those without insurance could find cost savings in over a quarter of their pharmacy fills, according to a study published Friday in JAMA Health Forum. Across a sample of nearly 844 ...
Since Nevada Medicaid resumed eligibility checks for beneficiaries in June of last year, only an average of 5 percent of Nevadans deemed ineligible for the publicly funded insurance program each month have managed to enroll in a plan through the state’s health insurance exchange.